Kane v. de Blasio
- Naomi Buchwald
- 1:21-cv-07863
- U.S. District Court · Southern District of New York
- 3
In Kane v. de Blasio, Judge Caproni granted recusal because her Pfizer stock could create an appearance of bias and reassigned the consolidated cases.
The plaintiffs and defendants in the two consolidated lawsuits were affected because the assigned judge stepped aside and the cases were ordered reassigned to another judge. The order did not resolve the challenge to the Department of Education’s COVID-19 vaccination requirement.
What happened
Kane v. de Blasio concerns challenges to New York City’s requirement that Department of Education employees be vaccinated against COVID-19 as a condition of continued employment. The court had consolidated this case with a similar lawsuit.
The plaintiffs asked the judge to step aside, arguing that her ownership of Pfizer stock created a financial conflict because Pfizer manufactured one of the authorized COVID-19 vaccines. They also argued that earlier rulings could raise questions about the judge’s objectivity.
Judge Valerie Caproni granted the recusal motion. Although she doubted that the cases would meaningfully affect Pfizer’s stock value and rejected the argument based on her prior rulings, she recused herself to avoid the appearance of bias or prejudice. The clerk was directed to close the motion and reassign both consolidated cases to another judge.
The detailed version
- Kane v. de Blasio · No. 1:21-cv-07863
- Naomi Buchwald
- June 11, 2022
Background
The plaintiffs in Kane v. de Blasio filed a lawsuit challenging New York City’s requirement that all employees of the New York City Department of Education be vaccinated against COVID-19 as a condition of continued employment. Plaintiffs in a second, similar case, Keil v. The City of New York, filed a separate lawsuit. The court consolidated the two cases on December 14, 2021.
On June 9, 2022, the plaintiffs moved for the judge’s recusal, meaning that she would step aside from the case. They argued that her ownership of Pfizer Inc. stock created a direct financial conflict because Pfizer was one of three manufacturers of COVID-19 vaccines authorized for use in the United States. They also argued that rulings in the case could raise questions about the judge’s objectivity.
Legal standard
The opinion cited federal law requiring a judge to disqualify herself when her impartiality might reasonably be questioned, or when she has a financial interest in the subject matter or another interest that could be substantially affected by the case’s outcome. The opinion emphasized that the relevant concern is the appearance of bias or prejudice, not only actual bias.
Ruling
The court granted the plaintiffs’ motion for recusal. Judge Valerie Caproni said she doubted that resolving the case—including deciding whether the Department of Education’s vaccine mandate remained in effect—would meaningfully affect the value of Pfizer stock. The court also rejected the argument that its earlier rulings showed partiality or bias, stating that judicial rulings almost never provide a valid basis for a bias motion. Even so, the judge recused herself out of caution to avoid the possible appearance of bias or prejudice.
The clerk was directed to close the motion at docket entry 171 and reassign consolidated cases 21-CV-7863 and 21-CV-8773 to another judge. This order addressed recusal and reassignment; it did not decide whether the vaccine mandate was lawful.
Read the full 3-page opinion on CourtListener, the free public archive maintained by the Free Law Project.